MedPlus Health Services Limited has announced key leadership changes following its board meeting on May 20, 2026. The board approved the appointment of two Non-Executive Independent Directors and the re-appointment of the Managing Director, all subject to shareholder approval.

Board Appointments

Based on the recommendation of the Nomination and Remuneration Committee, the board appointed Mr. Ajit Pandurang Rangnekar and Mr. Mohankrishna Reddy Arvabumi as Additional Directors designated as Non-Executive Independent Directors. Their appointments are effective May 20, 2026, for a first term of five years.

Mr. Rangnekar brings over 50 years of experience across manufacturing, services, and consulting, while Mr. Arvabumi offers over three decades of expertise in finance and strategy, having held senior roles at institutions like Indian Bank and ANZ Grindlays Bank.

Managing Director Re-appointment

The board approved the re-appointment of Mr. Gangadi Madhukar Reddy as Managing Director for a period of five years commencing August 03, 2026. A promoter of the company, Mr. Reddy has been associated with MedPlus since its inception and holds an MBA from The Wharton School.

The company affirmed that none of the appointed directors are debarred from holding the office of director by any SEBI order or other authority.

medplus health services has announced the resignation of its Company Secretary and Compliance Officer, Mr. Manoj Kumar Srivastava. The resignation was submitted via a letter dated May 5, 2026, and was accepted by the company's Board of Directors during its meeting held on May 20, 2026.

The Board placed on record its sincere appreciation for the contributions made by Mr. Srivastava during his tenure. He is stepping down from the position of Key Managerial Personnel (KMP) to pursue another career opportunity outside the organization. The resignation is effective from the close of business hours on May 20, 2026.

Details of the Change

The disclosure regarding the change in key managerial personnel was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The specific details regarding the cessation are outlined below:

In his resignation letter, Mr. Srivastava expressed his gratitude to the Chairman, Managing Director & CEO, the Board Members, and senior management for their trust and support. He confirmed his commitment to ensuring a smooth transition and extending full support during the handover process of his responsibilities.